Terbutaline
- Generic Name
- Terbutaline
- Brand Names
- Bricanyl
- Drug Type
- Small Molecule
- Chemical Formula
- C12H19NO3
- CAS Number
- 23031-25-6
- Unique Ingredient Identifier
- N8ONU3L3PG
- Background
Terbutaline was first synthesized in 1966 and described in the literature in the late 1960s and early 1970s. It is a selective beta-2 adrenergic agonist used as a bronchodilator in asthmatic patients.
Terbutaline was granted FDA approval on 25 March 1974.
- Indication
Terbutaline is indicated for prevention and reversal of bronchospasm in patients at least 12 years old, with asthma and reversible bronchospasm associated with bronchitis and emphysema.
- Associated Conditions
- Asthma, Bronchospasm, Chronic Cough (CC), Chronic Obstructive Pulmonary Disease (COPD), Cough, Premature Labour, Productive cough
- Associated Therapies
- Airway secretion clearance therapy
The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune Thrombocytopenia
- First Posted Date
- 2022-08-09
- Last Posted Date
- 2022-08-09
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 228
- Registration Number
- NCT05494307
Acute Tocolysis With Terbutaline for Suspected Fetal Distress
- First Posted Date
- 2022-04-13
- Last Posted Date
- 2022-04-13
- Lead Sponsor
- Hospital Kemaman
- Target Recruit Count
- 100
- Registration Number
- NCT05326269
- Locations
- 🇲🇾
Hospital Kemaman, Kuala Terengganu, Terengganu, Malaysia
Hot Flashes and Neurovascular Function in Women
- Conditions
- Interventions
- First Posted Date
- 2022-01-18
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 120
- Registration Number
- NCT05193968
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Terbutaline Sulfate in Adults With Asthma
- First Posted Date
- 2021-07-22
- Last Posted Date
- 2024-07-24
- Lead Sponsor
- Kanecia Obie Zimmerman
- Target Recruit Count
- 30
- Registration Number
- NCT04973345
- Locations
- 🇺🇸
Duke Early Phase Research Unit (DEPRU), Durham, North Carolina, United States
The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
- First Posted Date
- 2020-07-22
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT04481282
- Locations
- 🇨🇳
Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing, China
In Utero Repair of Myelomeningocele: Atosiban Versus Terbutaline
- Conditions
- Interventions
- First Posted Date
- 2020-07-13
- Last Posted Date
- 2022-06-06
- Lead Sponsor
- University of Sao Paulo General Hospital
- Target Recruit Count
- 25
- Registration Number
- NCT04468568
- Locations
- 🇧🇷
Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
Beta2-adrenergic Agonism and Muscle Remodelling
- Conditions
- Interventions
- First Posted Date
- 2018-06-21
- Last Posted Date
- 2020-03-25
- Lead Sponsor
- Morten Hostrup, PhD
- Target Recruit Count
- 72
- Registration Number
- NCT03565302
- Locations
- 🇩🇰
August Krogh Building, Copenhagen, Denmark
Success of External Cephalic Version Study
- First Posted Date
- 2017-04-10
- Last Posted Date
- 2020-10-09
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 34
- Registration Number
- NCT03106753
- Locations
- 🇺🇸
Mount Sinai West, New York, New York, United States
Role of K+ and Ca2+ in Development of Muscle Fatigue
- Conditions
- Interventions
- First Posted Date
- 2016-03-18
- Last Posted Date
- 2017-01-31
- Lead Sponsor
- University of Copenhagen
- Target Recruit Count
- 10
- Registration Number
- NCT02712658
- Locations
- 🇩🇰
Department of Nutrition, Exercise and Sports, Copenhagen, Denmark
cAMP Signaling and Muscle Adaptations
- First Posted Date
- 2015-09-23
- Last Posted Date
- 2017-10-26
- Lead Sponsor
- University of Copenhagen
- Target Recruit Count
- 72
- Registration Number
- NCT02557581
- Locations
- 🇩🇰
Bispebjerg University Hospital, Copenhagen, Denmark
🇩🇰Department of Nutrition, Exercise and Sports, Copenhagen, Denmark
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.